Hildegard Spahn‐Langguth

Author

Martin Luther University Halle-Wittenberg

Also Known As

Hildegard Spahn-Langguth, Hildegard Spahn‐Langguth

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Martin Luther University Halle-Wittenberg Goethe University Frankfurt Johannes Gutenberg University Mainz University of Michigan University of California, San Francisco

About

Hildegard Spahn‐Langguth is an author at Martin Luther University Halle-Wittenberg specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	957
2	Biochemistry	6	6	250
3	Natural Sciences	2	2	499
4	Engineering	1	1	35
5	Health Sciences	1	1	24

Hildegard Spahn‐Langguth

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Caco‐2 versus Caco‐2/HT29‐MTX Co‐cultured Cell Lines: Permeabilities Via Diffusion, Inside‐ and Outside‐Directed Carrier‐Mediated Transport Constanze Hilgendorf, Hildegard Spahn‐Langguth, C G Regårdh, Journal of Pharmaceutical Sciences Signal TransductionCell CommunicationPermeabilities Via DiffusionNatural SciencesMembrane Transport	2000	459
Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds — implications for pharmacokinetics of selected substrates Amal Abou el ela, Sebastian Härtter, Ulrich Schmitt, Journal of Pharmacy and Pharmacology	2004	138
Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday. Stephan Döppenschmitt, Hildegard Spahn‐Langguth, C G Regårdh, Journal of Pharmaceutical Sciences	1999	125
Species Difference in the Effect of Grapefruit Juice on Intestinal Absorption of Talinolol between Human and Rat Yoshiyuki Shirasaka, Erika Kuraoka, Hildegard Spahn‐Langguth, Journal of Pharmacology and Experimental Therapeutics	2009	121
Evidence for Intestinal Secretion as an Additional Clearance Pathway of Talinolol Enantiomers: Concentration- and Dose-dependent Absorption in Vitro and in Vivo U. Wetterich, Hildegard Spahn‐Langguth, E. Mutschler, Pharmaceutical Research	1996	110
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability N. Ceren Alemdaroglu, Ulrich A. Dietz, Siegfried Wolffram, Biopharmaceutics & Drug Disposition	2008	90
Concentration-Dependent Effect of Naringin on Intestinal Absorption of β1-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp) Yoshiyuki Shirasaka, Yan Li, Yuta Shibue, Pharmaceutical Research Molecular PharmacologyBiochemistryGastrointestinal PharmacologyMedicinePhysiology	2008	86
Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay Stephan Döppenschmitt, Peter Langguth, C G Regårdh, Journal of Pharmacology and Experimental Therapeutics	1999	75
HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats Andrea Soldner, Hildegard Spahn‐Langguth, E. Mutschler Journal of Pharmaceutical and Biomedical Analysis Angiotensin-at1 Antagonist LosartanBiological MaterialMedicineVascular PharmacologyPhysiology	1998	68
Celiprolol double-peak occurrence and gastric motility: Nonlinear mixed effects modeling of bioavailability data obtained in dogs Elke Lipka, I-Der Lee, Peter Langguth, Journal of Pharmacokinetics and Biopharmaceutics Animal PhysiologyVeterinary PhysiologyCeliprolol Double-peak OccurrenceMedicinePhysiology	1995	55

Page 1